DXCM
DEXCOM INC
DEXCOM INC (DXCM) has 19 SEC Form 4 filings (25 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 16, 2026.
Insiders have net sold $3.2M over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Jacob Steven Leach
- Employees:10,200
- HQ:San Diego, CA, US
- IPO:2005-04-14
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.2M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$29.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| EVP Chief Legal Compliance Off | Sale | 1,700 | $127K | Jul 16 | SEC ↗ | |
SAYER KEVIN RFirst filing | Executive Chair | Sale | 26,756 | $1.9M | Jul 7 | SEC ↗ |
FOLETTA MARK GFirst filing | Director | Sale | 4,000 | $297K | Jun 17 | SEC ↗ |
Brown Michael JonFirst filing | EVP Chief Legal Compliance Off | Sale | 1,700 | $128K | Jun 17 | SEC ↗ |
Coleman JonFirst filing | EVP, Chief Commercial Officer | Sale | 4,912 | $359K | Jun 5 | SEC ↗ |
Coleman JonFirst filing | EVP, Chief Commercial Officer | Sale | 4,911 | $364K | Jun 5 | SEC ↗ |
Congress trading DXCM
See timeline →- DRep. Ro KhannaPurchase$1,001 - $15,0002026-05-01
- DRep. Ro KhannaPurchase$1,001 - $15,0002026-04-13
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
DEXCOM INC is in the Healthcare sector.